Marshall Wace’s Kymera Therapeutics KYMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-38,022
Closed -$2.96M 3486
2025
Q4
$2.96M Sell
38,022
-321,054
-89% -$21.7M ﹤0.01% 1395
2025
Q3
$20.3M Buy
359,076
+89,792
+33% +$4.05M 0.02% 647
2025
Q2
$11.8M Buy
269,284
+67,384
+33% +$2.32M 0.01% 788
2025
Q1
$5.53M Buy
201,900
+195,065
+2,854% +$7.11M 0.01% 1013
2024
Q4
$275K Sell
6,835
-110,846
-94% -$5.01M ﹤0.01% 2255
2024
Q3
$5.57M Sell
117,681
-258,881
-69% -$11.4M 0.01% 957
2024
Q2
$11.2M Sell
376,562
-196,364
-34% -$6.8M 0.02% 683
2024
Q1
$23M Buy
+572,926
New +$20.5M 0.04% 463
2023
Q4
Sell
-54,837
Closed -$762K 2438
2023
Q3
$762K Sell
54,837
-209,081
-79% -$4.2M ﹤0.01% 1582
2023
Q2
$6.07M Buy
+263,918
New +$7.56M 0.01% 939
2021
Q2
Sell
-14,698
Closed -$571K 2892
2021
Q1
$571K Buy
+14,698
New +$885K ﹤0.01% 1891

Other funds holding KYMR